Vital Metals Limited notes that Peak Asset Management has initiated research coverage on the Company
17 May 2026
Key Points
Target valuation range of A$0.22 to A$0.38 per share.
Risk-adjusted NPV of A$297.95 million (base case) and A$422.50 million (upside case) for the Nechalacho Project, underpinned by the July 2025 Tardiff Scoping Study.
8% discount rate and 0.61x stage-based risk adjustment applied.
February 2027 Tardiff Pre-Feasibility Study identified as a key de-risking catalyst, with confirmation of niobium payability flagged as potential additional upside.
Potential near-term cash flow from the processing of existing North T stockpiles is identified as a further catalyst.
Project economics are derisked by the U.S. Department of War's US$110/kg NdPr floor price.
